Jane Street’s Anixa Biosciences ANIX Stock Holding History

Jane Street’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,800	Closed	-$132K	–	10708
2025 Q2	$138K	Buy	41,800 +11,340	+37%	+$32.4K	﹤0.01%	8803
2025 Q1	$87.1K	Buy	30,460 +1,614	+6%	+$4.62K	﹤0.01%	8872
2024 Q4	$66.9K	Buy	+28,846	New	+$89.6K	﹤0.01%	8895
2024 Q2	–	Sell	-121,924	Closed	-$380K	–	9286
2024 Q1	$380K	Buy	121,924 +78,541	+181%	+$313K	﹤0.01%	7161
2023 Q4	$168K	Buy	+43,383	New	+$146K	﹤0.01%	8332
2023 Q2	–	Sell	-61,810	Closed	-$266K	–	8623
2023 Q1	$266K	Buy	+61,810	New	+$271K	﹤0.01%	7390
2021 Q2	–	Sell	-26,093	Closed	-$122K	–	9719
2021 Q1	$122K	Buy	+26,093	New	+$125K	﹤0.01%	8561
2020 Q4	–	Sell	-18,495	Closed	-$45K	–	7423
2020 Q3	$45K	Buy	+18,495	New	+$47.7K	﹤0.01%	6930

Other funds holding ANIX

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street's ANIX Position: Q3 2025 in Review

Jane Street sold out of Anixa Biosciences (ANIX) in Q3 2025, closing a stake of 41,800 shares — an estimated $132K sold.

Jane Street first reported a position in ANIX in Q3 2020 and held it in 8 quarters. The position peaked at $380K in Q1 2024. 66 funds tracked by Wall St. Rank hold ANIX as of Q3 2025.

Jane Street reported no remaining Anixa Biosciences position as of Q3 2025 after selling out during the quarter.
Jane Street sold 41,800 Anixa Biosciences shares in Q3 2025, an estimated $132K.
Jane Street first reported a position in Anixa Biosciences in Q3 2020 and held it in 8 quarters.
Jane Street's Anixa Biosciences position peaked at $380K in Q1 2024.
66 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.